EIF2AK4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.209400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.050400E-01
Normal-vs-Stage2
4.096000E-01
Normal-vs-Stage3
3.506200E-01
Normal-vs-Stage4
3.742800E-01
Stage1-vs-Stage2
1.782230E-01
Stage1-vs-Stage3
3.842600E-01
Stage1-vs-Stage4
2.926200E-01
Stage2-vs-Stage3
5.473400E-01
Stage2-vs-Stage4
6.063400E-01
Stage3-vs-Stage4
9.554400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.503400E-01
Normal-vs-AfricanAmerican
4.410000E-01
Normal-vs-Asian
2.162200E-01
Caucasian-vs-AfricanAmerican
7.848200E-01
Caucasian-vs-Asian
2.065800E-01
AfricanAmerican-vs-Asian
5.836000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.699000E-01
Normal-vs-Female
6.754800E-01
Male-vs-Female
2.898600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.995200E-01
Normal-vs-Age(41-60Yrs)
7.218800E-01
Normal-vs-Age(61-80Yrs)
3.187600E-01
Normal-vs-Age(81-100Yrs)
3.762200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.421600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.788800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.581800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.214030E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.180400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.335600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.109000E-01
Normal-vs-Daily Drinker
5.351400E-01
Normal-vs-Weekly Drinker
7.599400E-01
Normal-vs-Occasional Drinker
2.222200E-01
Normal-vs-Social Drinker
9.005000E-01
Non Drinker-vs-Daily Drinker
4.168000E-01
Non Drinker-vs-Weekly Drinker
1.372990E-01
Non Drinker-vs-Occasional Drinker
7.783600E-01
Non Drinker-vs-Social Drinker
6.103600E-02
Daily Drinker-vs-Weekly Drinker
5.528600E-01
Daily Drinker-vs-Occasional Drinker
6.120800E-01
Daily Drinker-vs-Social Drinker
3.613800E-01
Weekly Drinker-vs-Occasional Drinker
2.336600E-01
Weekly Drinker-vs-Social Drinker
7.675200E-01
Occasional Drinker-vs-Social Drinker
1.240570E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.496200E-01
Normal-vs-Grade 2
8.880200E-01
Normal-vs-Grade 3
8.403200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.297200E-01
Grade 1-vs-Grade 3
7.646200E-02
Grade 1-vs-Grade 4
9.496200E-01
Grade 2-vs-Grade 3
2.439600E-01
Grade 2-vs-Grade 4
8.880200E-01
Grade 3-vs-Grade 4
8.403200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.902400E-01
Normal-vs-NonDiabetic
4.685200E-01
Diabetic-vs-NonDiabetic
1.440210E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.965000E-01
Normal-vs-NoPancreatitis
3.955800E-01
Pancreatitis-vs-NoPancreatitis
1.089640E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.317200E-01
Normal-vs-N1
4.487600E-01
N0-vs-N1
8.905000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.300000E-01
Normal-vs-TP53-NonMutant
4.508200E-01
TP53-Mutant-vs-TP53-NonMutant
1.879210E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
